Confirmed Speakers

Richard Auchus, MD, PhD
Professor, Internal Medicine
University of Michigan
Michigan, United States of America


Dr. Richard Auchus is a Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and director of the MEND Fellowship Program. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine – Endocrinology.


Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury.

Shehzad Basaria, MD, MBBS
Associate Professor of Medicine and Medical Director
Section of Men’s Health, Aging and Metabolism
Brigham and Women’s Hospital
Harvard Medical School

Massachusetts, United States of America


Dr. Shehzad Basaria is an expert in the field of Andrology who has joined the Section of Endocrinology at BUMC as the Clinical Director of Androgen Clinical Research Unit (ACRU). Dr. Basaria’s primary role is the promotion of clinical research at ACRU. Dr. Basaria has research funding from the National Institute on Aging and from Industry and conducts his own research in the field of Endocrine Oncology (evaluating endocrine complications of castration in men with prostate cancer) and Endocrinology of Aging (testosterone replacement in elderly men). He is also evaluating the role of testosterone replacement in men with opioid-induced hypogonadism.


In addition to his own research, Dr. Basaria supervises and directs all of the clinical research that takes place within ACRU. Dr. Basaria currently oversees 7 clinical trials at ACRU that focus on the role of testosterone on physical function, sexual dysfunction, atherosclerosis, pain perception and quality of life in men and women.

Pauline M. Camacho, MD, FACE
President, American Association of Clinical Endocrinologist
Director, Professor of Medicine

Loyola University Osteoporosis and Metabolic Bone Disease Center
Loyola University Medical Center

Illinois, United States of America


Pauline Camacho MD, FACE is a Professor of Medicine at Loyola University Medical Center and is the Director of the Loyola University Osteoporosis Metabolic Bone Disease Center. She also directs the Endocrinology Fellowship program at Loyola.


She has published three books on endocrinology: Evidence Based Endocrinology, Osteoporosis: A Guide for Clinicians, and a Color Handbook of Clinical Endocrinology and Metabolism. She has authored numerous publications and presented in national and international meetings. She is a member of the Board of Directors of the American Association of Clinical Endocrinologists and is on the editorial board of Endocrine Practice and Journal of Clinical Densitometry.


Dr. Camacho completed medical school at the University of the Philippines and her residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago. She maintains an active endocrinology practice.

Seán Dinneen, MB, BCH, BAO, MSC, MD
Consultant Endocrinologist
Galway University Hospitals
Galway, Ireland


Dr. Seán Dinneen graduated from University College Cork Medical School in 1985. After a period of postgraduate training in Ireland he travelled to the USA where he completed training in Internal Medicine and Endocrinology at the Mayo Clinic in Rochester, Minnesota. He was awarded a Mayo Foundation Scholarship and completed a Masters in Clinical Epidemiology at McMaster University, Hamilton, Ontario, Canada before returning to a staff position at the Mayo Clinic in the Division of Endocrinology with a joint appointment to the Division of Health Services Research. In 2000 he was appointed as a Community Diabetologist in Addenbrooke’s Hospital, Cambridge, UK, one of the first such appointments in the NHS. Dr. Dinneen returned to Ireland in 2005 as a Senior Lecturer in Medicine (NUI Galway) and Consultant Endocrinologist (Galway University Hospitals). In December 2013 Dr. Dinneen was appointed Head of the School of Medicine in NUI Galway.


His professional interests include developing and evaluating programmes of self-management education for people with diabetes, developing optimal models of community-based diabetes care and understanding the diabetic foot. Over the past 10 years he has secured research funding of over 2,250,000 from the Health Research Board, Enterprise Ireland, Diabetes Ireland (through the Medical Research Charities Group) and the European Foundation for the Study of Diabetes. In addition, he was part of successful bids which brought a School of Podiatry and a Clinical Research Facility to NUI Galway. He has acted as PI on 3 multi-centre clinical trials through the CRFG. Dr. Dinneen has served as National Specialty Director for Endocrinology and Diabetes Mellitus in the Royal College of Physicians of Ireland since 2009; in this role he oversees all aspects of postgraduate training of Endocrinology Trainees in the Republic of Ireland. In 2014 Dr. Dinneen was honored with the Nordisk Medal from the Irish Endocrine Society; this medal is awarded to a member of the Society in recognition of a body of research work carried out on the island of Ireland. Dr. Dinneen delivered the Annual Nordisk Lecture entitled “Exploring the Chronic Care Model: a Diabetes Journey”.


Recent professional achievements include delivering to completion a large multi-centre study evaluating 2 different methods of follow-up of patients with type 1 diabetes following structured education (the Irish DAFNE Study), delivering to completion a cohort study assessing risk factors for foot ulceration in a community cohort (The West of Ireland Diabetes Foot Study) and being appointed Chair of the EASD’s (Extra-European) Postgraduate Education Committee (April 2013). Recent personal achievements include climbing Mount Kilimanjaro (2007), learning to swim (2009), walking the last 110 km of the Camino de Santiago (2010) and trekking the Haute Route from Chamonix to Zermatt (2014).

Amir H. Hamrahian, MD
Chief of Endocrinology
Medical Subspecialties Institute
Cleveland Clinic Abu Dhabi

Abu Dhabi, United Arab Emirates


Dr. Amir Hamrahian is the chief of Endocrinology in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi. He has received his medical degree from Hacettepe University in Ankara, Turkey. He did his internal medicine residency at the University of North Dakota and endocrinology fellowship at Case Western Reserve University. He joined Cleveland Clinic in 2000 and Cleveland Clinic Abu Dhabi as a seconded physician in 2014. He specializes in Endocrinology, Diabetes, and Metabolism and has special interest in pituitary and adrenal disorders. Dr. Hamrahian has published more than 70 peer reviewed articles, along with more than 75 abstracts and book chapters. He has given presentations on pituitary and adrenal disorders at national meetings and has served as the principal investigator for a number of pituitary related clinical research studies. He initiated and co-directed an annual Pituitary Day Conference in Cleveland from 2005 to 2014. He is professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.


Ahmed A.K. Hassoun, MD, FACE, FACP
Associate Professor, Consultant Endocrinologist
Dubai Medical University, Dubai Diabetes Center
Dubai, United Arab Emirates


Dr. Hassoun completed his residency training in Internal Medicine at Brown University – Rhode Island, USA. After 3 years of extensive clinical and research fellowship in Endocrinology, Diabetes & Metabolism at the Mayo Clinic in Rochester, Minnesota, he joined the Endocrinology staff at Mayo Clinic. He is American board certified in both Internal Medicine & Endocrinology, Diabetes, and Metabolism.  Dr. Hassoun is a fellow of the American College of Physicians and the American College of Endocrinology. In addition, he is an active member of: American Diabetes Association(ADA), the Endocrine Society (ES), and the American Association of Clinical Endocrinologists (AACE). His previous appointments included: Chief of Endocrinology, Emirates Diabetes Society Board member, Clinical Assistant Professor at Wayne State University in Michigan and the Faculty of Medicine at the UAE University. He has been actively participating in: developing and updating the UAE Diabetes guidelines, educating & training doctors & other healthcare providers, as well as conducting research in the field of diabetes & endocrinology.  Dr. Hassoun is a founding member and active coordinator of the monthly UAE Endocrinology meetings, which was established in the year 2000, to encourage up-to-date education and dialogue amongst endocrinologists.

Melissa Li-Ng, MD
Consultant Endocrinologist
Cleveland Clinic Abu Dhabi
Abu Dhabi, United Arab Emirates


Melissa Li-Ng, MD, is a Staff Physician in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi.


Prior to joining Cleveland Clinic Abu Dhabi, Dr. Li-Ng worked with the Endocrinology and Metabolism Institute of Cleveland Clinic, Ohio, where she was involved in medical education activities with medical students, residents and fellows. She served as the Associate Program Director of the Endocrinology Fellowship Program for three years before joining Cleveland Clinic Abu Dhabi.


Dr. Li-Ng has published and presented research and case studies on a variety of endocrine conditions. Her clinical interests include diabetes, thyroid disease, thyroid cancer, pituitary disease, polycystic ovarian syndrome, metabolic syndrome, osteoporosis, vitamin D deficiency, parathyroid gland disease, and adrenal gland disorders.


Dr. Li-Ng completed a research fellowship at the Bone Mineral Research Center at Winthrop University Hospital in New York, carrying out research on osteoporosis, vitamin D and bone metabolism. Dr. Li-Ng then completed her Endocrinology Fellowship at Georgetown University Hospital and Washington Hospital Center in Washington, D.C.


Dr. Li-Ng received her medical degree from Stony Brook School of Medicine in New York. She completed her medical residency at New York University Medical Center.

Ebaa Al-Ozairi, MRCP(UK), CCST, FACN
Assistant Professor, Consultant Endocrinologist & Nutritionist
University of Kuwait
Kuwait City, Kuwait


Dr. Ebaa Al-Ozairi is an Assistant Professor at Kuwait University and a Consultant Diabetes, Endocrine and Nutrition. She is an Honorary Senior Lecturer at Dundee University UK. Dr. Al Ozairi has completed her intercalated BMSc (hons) in molecular pathology at Dundee University (UK) and graduated from Aberdeen University (UK) for her medical undergraduate studies. Dr. Al Ozairi then joined Newcastle University (UK) for her specialist training in Diabetes and Endocrinology. During her postgraduate studies in UK, Dr. Al Ozairi was awarded The Fulbright fellowship to Joslin Diabetes Center, affiliated with Harvard Medical School, Boston, USA.



Her research interest includes diabetes education, technology, metabolic surgery and obesity. Ebaa has been accredited by the Royal College of physician (UK) as a medical educator, and is an associate practitioner at the UK Higher Education National Academy having completed teaching fellowship. She has completed her fellowship in obesity and holds the American Board for Physician Nutrition Specialist and is a fellow at the American College of Nutrition. She also directs DAFNE type 1 diabetes education program and currently is granted the training centre for the Middle East. Dr. Alozairi has completed her Rabkin Fellowship in Medical Education at Harvard Medical School. Dr. Al-Ozairi is on the editorial board for Austin Medical Journal and the Journal of community medicine and public health. She is also a reviewer for Diabetic Medicine, Obesity Surgery, Practical International Diabetes. She has 3 chapters in International books and an author in medscape, bariatric times and Endodiabology. Dr. Alozairi has won his highness the Amir Gold medal electronic award and the Arab regional award for founding In addition, she is the Treasurer/Secretary of the American Association of Clinical Endocrinologist- Gulf Chapter.

Nasreen Alsayed, MD, FACP
Medical Director, Endocrinologist & Lipidologist
Gulf Diabetes Center
Manama, Bahrain


Dr. Nasreen Al-Sayed graduated from Arabian Gulf University, college of Medicine in Bahrain. She is American Board Certified. She completed her residency training in Internal medicine at Sinai-Grace Hospital, Wayne State University, Detroit, Michigan, USA and Fellowship training in Endocrinology and Diabetes at Cleveland Clinic Foundation, Ohio, and USA. Dr. Al-Sayed is also American Board Certified in Clinical Lipidology and is the first physician to have board certification in lipids in Middle East. Dr. Al-Sayed is a fellow of American College of Physicians. She is a member of many Diabetes and Endocrine Associations such as the American Diabetes Association, the American Association of Clinical Endocrinologists, The American College of Physicians, The National Lipid Association and has several research publications.

Dr. Al-Sayed has a special interest in clinical diabetes, thyroid disorders, parathyroid disorders, osteoporosis, pituitary disorders, adrenal disorders, polycystic ovary syndrome and hirsutism. She is first physician in Middle East with experience in treating resistant cases of hyperparathyroidism with parathyroid hormone. She has also teaching experience and served as an Assistant Professor at Arabian Gulf University, College of Medicine & Medical Sciences.

Ali Alzahrani, MD, FACE
Consultant Endocrinologist
King Faisal Specialist Hospital Research Centre
Professor of Medicine
Alfaisal University
Riyadh, Saudi Arabia


Dr. Ali S. Alzahrani is a Professor of Medicine and Endocrinology at Al Faisal University in Riyadh.  Dr. Ali Zahrani obtained his Medical Degree from King Saud University in 1990. This was followed by Residency in Internal Medicine at KFSH & RC during the period 1991-1995 and Clinical and Research Fellowship at the John Hopkins School of Medicine in Baltimore, USA during the years 1995-1998.  He has been a Consultant Endocrinologist at KFSH & RC since 1998.   During the period 2010 to 2011, Dr. Alzahrani was a faculty member and visiting Scientist at the Division of Endocrinology and Metabolism in John Hopkins University, School of Medicine, Baltimore, United States of America.  Since his return late in 2011, he has become a Scientist and Head of the Molecular Endocrinology Division in the Department of Molecular Oncology, Research Center in addition to his Consultant Endocrinology position.  Most recently, he has been appointed as a Deputy Executive Director, Research Center at KFSH & RC, Jeddah.


Dr. Alzahrani is proactive in several editorial boards of famously known medical publications. He was the Editor-in Chief of the Annals of Saudi Medicine and an Editorial Board Member of the British Journal of Diabetes and Vascular Medicine. He is an Editorial Board member of the prestigious official journal of the American Thyroid Association, THYROID.  Dr. Alzahrani has more than 70 peer-reviewed articles, more than ninty regional and international presentations and has conducted more than ninety lectures nationally and internationally as an invited speaker. Dr. Al Zahrani’s academic interests are clinical and molecular research in the areas of thyroid cancer and endocrine genetics.